{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T00:11:59Z","timestamp":1793664719719,"version":"4.5.1"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Ocular Surface"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.jtos.2025.05.003","type":"journal-article","created":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T02:34:27Z","timestamp":1746758067000},"page":"273-282","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Ranking the efficacy of topical treatments for ocular allergy: A network meta-analysis of current evidence"],"prefix":"10.1016","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0806-8264","authenticated-orcid":false,"given":"Luksanaporn","family":"Krungkraipetch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taweelarp","family":"Tansavadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dechathorn","family":"Krungkraipetch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jtos.2025.05.003_bib1","doi-asserted-by":"crossref","first-page":"45","DOI":"10.4274\/tjo.galenos.2020.11456","article-title":"Current knowledge in allergic conjunctivitis","volume":"51","author":"Villegas","year":"2021","journal-title":"Turk J Ophthalmol"},{"issue":"1","key":"10.1016\/j.jtos.2025.05.003_bib2","doi-asserted-by":"crossref","first-page":"45","DOI":"10.4274\/tjo.galenos.2020.11456","article-title":"Current knowledge in allergic conjunctivitis","volume":"51","author":"Vidal Villegas","year":"2021","journal-title":"Turk J Ophthalmol"},{"issue":"3 Pt 1","key":"10.1016\/j.jtos.2025.05.003_bib3","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0091-6749(99)70463-X","article-title":"Direct expenditures for the treatment of allergic rhinoconjunctivitis in 1996, including the contributions of related airway illnesses","volume":"103","author":"Ray","year":"1999","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.jtos.2025.05.003_bib4","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.anai.2020.11.016","article-title":"The spectrum of allergic ocular diseases","volume":"126","author":"Rodrigues","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"6","key":"10.1016\/j.jtos.2025.05.003_bib5","doi-asserted-by":"crossref","first-page":"650","DOI":"10.3390\/life14060650","article-title":"Allergic conjunctivitis: review of current types, treatments, and trends","volume":"14","author":"Tariq","year":"2024","journal-title":"Life"},{"issue":"2","key":"10.1016\/j.jtos.2025.05.003_bib6","first-page":"118","article-title":"Diagnosis and management of allergic conjunctivitis","volume":"124","author":"Bielory","year":"2020","journal-title":"Special Series"},{"issue":"16","key":"10.1016\/j.jtos.2025.05.003_bib7","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1001\/jama.2013.280318","article-title":"Conjunctivitis: a systematic review of diagnosis and treatment","volume":"310","author":"Azari","year":"2013","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.jtos.2025.05.003_bib8","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jaad.2020.11.037","article-title":"Bidirectional association between atopic dermatitis, conjunctivitis, and other ocular surface diseases: a systematic review and meta-analysis","volume":"85","author":"Ravn","year":"2021","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jtos.2025.05.003_bib9","doi-asserted-by":"crossref","first-page":"372","DOI":"10.18502\/jovr.v15i3.7456","article-title":"Conjunctivitis: a systematic review","volume":"15","author":"Azari","year":"2020","journal-title":"J Ophthalmic Vis Res"},{"issue":"7","key":"10.1016\/j.jtos.2025.05.003_bib10","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/j.1398-9995.2010.02536.x","article-title":"Clinical trials in allergic conjunctivitis: a systematic review","volume":"66","author":"Mantelli","year":"2011","journal-title":"Allergy"},{"key":"10.1016\/j.jtos.2025.05.003_bib11","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1824-7288-39-18","article-title":"Allergic conjunctivitis: a comprehensive review of the literature","volume":"39","author":"La Rosa","year":"2013","journal-title":"Ital J Pediatr"},{"issue":"1","key":"10.1016\/j.jtos.2025.05.003_bib12","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s11739-016-1583-7","article-title":"Network meta-analysis: an introduction for clinicians","volume":"12","author":"Rouse","year":"2016","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.jtos.2025.05.003_bib13","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s12886-023-02866-9","article-title":"Systematic analysis of levels of evidence supporting American Academy of Ophthalmology preferred practice pattern guidelines, 2012\u20132021","volume":"23","author":"Song","year":"2023","journal-title":"BMC Ophthalmol"},{"issue":"12","key":"10.1016\/j.jtos.2025.05.003_bib14","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2023-013109","article-title":"The use of network meta-analysis in updating WHO living maternal and perinatal health recommendations","volume":"8","author":"Williams","year":"2023","journal-title":"BMJ Glob Health"},{"issue":"6","key":"10.1016\/j.jtos.2025.05.003_bib15","first-page":"829","article-title":"Assessment of the strength of recommendation and quality of evidence: GRADE checklist. A descriptive study","volume":"140","author":"Bezerra","year":"2022","journal-title":"Sao Paulo Med J"},{"key":"10.1016\/j.jtos.2025.05.003_bib16","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"Br Med J"},{"key":"10.1016\/j.jtos.2025.05.003_bib17","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"Br Med J"},{"key":"10.1016\/j.jtos.2025.05.003_bib18","author":"Schwarzer"},{"issue":"3","key":"10.1016\/j.jtos.2025.05.003_bib19","doi-asserted-by":"crossref","first-page":"167","DOI":"10.18176\/jiaci.0894","article-title":"Bilastine 0.6% preservative-free eye drops: a once-daily treatment for allergic conjunctivitis","volume":"34","author":"Gomes","year":"2024","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"10","key":"10.1016\/j.jtos.2025.05.003_bib20","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1136\/bjo.87.10.1206","article-title":"Efficacy and safety of ketotifen eye drops in the treatment of seasonal allergic conjunctivitis","volume":"87","author":"Kidd","year":"2003","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"10.1016\/j.jtos.2025.05.003_bib21","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1136\/bjo.2003.021907","article-title":"Randomised double-masked trial comparing the efficacy and tolerance of 0.05% mequitazine eye drops versus 0.05% levocabastine and placebo in allergic conjunctivitis induced by a conjunctival provocation test with Dermatophagoides pteronyssinus","volume":"88","author":"Mortemousque","year":"2004","journal-title":"Br J Ophthalmol"},{"issue":"11","key":"10.1016\/j.jtos.2025.05.003_bib22","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1038\/s41433-022-02342-6","article-title":"Topical cyclosporine A cationic ophthalmic emulsion in paediatric vernal keratoconjunctivitis: pooled analysis of randomised NOVATIVE and VEKTIS trials","volume":"37","author":"Leonardi","year":"2023","journal-title":"Eye (Lond)."},{"issue":"6","key":"10.1016\/j.jtos.2025.05.003_bib23","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s10384-024-01108-9","article-title":"Safety and efficacy of a novel 0.5% epinastine topical eyelid cream in allergic conjunctivitis: a phase 3 trial","volume":"68","author":"Fujishima","year":"2024","journal-title":"Jpn J Ophthalmol"},{"issue":"11","key":"10.1016\/j.jtos.2025.05.003_bib24","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.jfma.2011.09.004","article-title":"A double-masked study to compare the efficacy and safety of topical cromolyn for the treatment of allergic conjunctivitis","volume":"110","author":"Liu","year":"2011","journal-title":"J Formos Med Assoc"},{"issue":"3","key":"10.1016\/j.jtos.2025.05.003_bib25","doi-asserted-by":"crossref","first-page":"154","DOI":"10.5935\/0004-2749.20170038","article-title":"Tacrolimus eye drops as monotherapy for vernal keratoconjunctivitis: a randomized controlled trial","volume":"80","author":"M\u00fcller","year":"2017","journal-title":"Arq Bras Oftalmol"},{"issue":"9","key":"10.1016\/j.jtos.2025.05.003_bib26","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.4103\/ijo.IJO_2112_18","article-title":"Observer-masked trial comparing efficacy of topical olopatadine (0.1%), bepotastine (1.5%), and alcaftadine (0.25%) in mild to moderate allergic conjunctivitis","volume":"67","author":"Dudeja","year":"2019","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.jtos.2025.05.003_bib27","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.ajo.2021.03.017","article-title":"Phase 3 randomized study of efficacy and safety of a dexamethasone intracanalicular insert in patients with allergic conjunctivitis","volume":"229","author":"McLaurin","year":"2021","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"10.1016\/j.jtos.2025.05.003_bib28","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/ICO.0000000000001911","article-title":"Management of ocular allergy itch with an antihistamine-releasing contact lens","volume":"38","author":"Pall","year":"2019","journal-title":"Cornea"},{"issue":"12","key":"10.1016\/j.jtos.2025.05.003_bib29","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1136\/bjo.2007.117515","article-title":"Clinical and biological efficacy of preservative-free NAAGA eye-drops versus levocabastine eye-drops in vernal keratoconjunctivitis patients","volume":"91","author":"Leonardi","year":"2007","journal-title":"Br J Ophthalmol"},{"issue":"10","key":"10.1016\/j.jtos.2025.05.003_bib30","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1007\/s12325-014-0156-2","article-title":"Efficacy of olopatadine versus epinastine for treating allergic conjunctivitis caused by Japanese cedar pollen: a double-blind randomized controlled trial","volume":"31","author":"Fukushima","year":"2014","journal-title":"Adv Ther"},{"issue":"2","key":"10.1016\/j.jtos.2025.05.003_bib31","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2332\/allergolint.55.157","article-title":"Efficacy of levocabastine hydrochloride ophthalmic suspension in the conjunctival allergen challenge test in Japanese subjects with seasonal allergic conjunctivitis","volume":"55","author":"Takamura","year":"2006","journal-title":"Allergol Int"},{"issue":"5","key":"10.1016\/j.jtos.2025.05.003_bib32","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.ophtha.2018.12.027","article-title":"A randomized, controlled trial of cyclosporine A cationic emulsion in pediatric vernal keratoconjunctivitis: the VEKTIS study","volume":"126","author":"Leonardi","year":"2019","journal-title":"Ophthalmology"},{"issue":"11","key":"10.1016\/j.jtos.2025.05.003_bib33","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1136\/bjo.84.11.1228","article-title":"Anti-inflammatory and antiallergic effects of ketorolac tromethamine in the conjunctival provocation model","volume":"84","author":"Leonardi","year":"2000","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"10.1016\/j.jtos.2025.05.003_bib34","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1089\/jop.2009.0087","article-title":"A randomized, placebo-controlled clinical trial of tacrolimus ophthalmic suspension 0.1% in severe allergic conjunctivitis","volume":"26","author":"Ohashi","year":"2010","journal-title":"J Ocul Pharmacol Therapeut"},{"issue":"3","key":"10.1016\/j.jtos.2025.05.003_bib35","first-page":"177","article-title":"A double-masked comparison of 0.1% tacrolimus ointment and 2% cyclosporine eye drops in the treatment of vernal keratoconjunctivitis in children","volume":"30","author":"Labcharoenwongs","year":"2012","journal-title":"Asian Pac J Allergy Immunol"},{"issue":"2","key":"10.1016\/j.jtos.2025.05.003_bib36","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.alit.2016.08.011","article-title":"Evaluating the efficacy of epinastine ophthalmic solution using a conjunctivitis allergen challenge model in patients with birch pollen allergic conjunctivitis","volume":"66","author":"Tagawa","year":"2017","journal-title":"Allergol Int"},{"key":"10.1016\/j.jtos.2025.05.003_bib37","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ajo.2019.11.020","article-title":"Twelve-month results of cyclosporine A cationic emulsion in a randomized study in patients with pediatric vernal keratoconjunctivitis","volume":"212","author":"Bremond-Gignac","year":"2020","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.jtos.2025.05.003_bib38","doi-asserted-by":"crossref","first-page":"455","DOI":"10.17219\/acem\/37145","article-title":"Topical cyclosporine A 0.05% eyedrops in the treatment of vernal keratoconjunctivitis - randomized placebo-controlled trial","volume":"23","author":"Keklikci","year":"2014","journal-title":"Adv Clin Exp Med"},{"issue":"4","key":"10.1016\/j.jtos.2025.05.003_bib39","first-page":"241","article-title":"Supratarsal injection of corticosteroids in the treatment of refractory vernal keratoconjunctivitis","volume":"49","author":"Singh","year":"2001","journal-title":"Indian J Ophthalmol"},{"issue":"4","key":"10.1016\/j.jtos.2025.05.003_bib40","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1136\/bjo.2005.082461","article-title":"Randomised controlled trial of topical ciclosporin A in steroid dependent allergic conjunctivitis","volume":"90","author":"Daniell","year":"2006","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"10.1016\/j.jtos.2025.05.003_bib41","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1600-0420.2006.00620.x","article-title":"Comparison of the efficacy of olopatadine hydrochloride 0.1% ophthalmic solution and artificial tears in seasonal allergic conjunctivitis","volume":"84","author":"Kamis","year":"2006","journal-title":"Acta Ophthalmol Scand"},{"issue":"10","key":"10.1016\/j.jtos.2025.05.003_bib42","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s12325-014-0155-3","article-title":"Ocular itch relief with alcaftadine 0.25% versus olopatadine 0.2% in allergic conjunctivitis: pooled analysis of two multicenter randomized clinical trials","volume":"31","author":"McLaurin","year":"2014","journal-title":"Adv Ther"},{"issue":"4","key":"10.1016\/j.jtos.2025.05.003_bib43","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/alr.21882","article-title":"Efficacy of olopatadine hydrochloride 0.1%, emedastine difumarate 0.05%, and loteprednol etabonate 0.5% for Chinese children with seasonal allergic conjunctivitis: a randomized vehicle-controlled study","volume":"7","author":"Liu","year":"2017","journal-title":"Int Forum Allergy Rhinol"},{"issue":"4","key":"10.1016\/j.jtos.2025.05.003_bib44","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1034\/j.1600-0420.2003.00079.x","article-title":"Comparative study of 0.1% olopatadine hydrochloride and 0.5% ketorolac tromethamine in the treatment of seasonal allergic conjunctivitis","volume":"81","author":"Yaylali","year":"2003","journal-title":"Acta Ophthalmol Scand"},{"issue":"9","key":"10.1016\/j.jtos.2025.05.003_bib45","first-page":"1091","article-title":"Efficacy of olopatadine HCl 0.1%, ketotifen fumarate 0.025%, epinastine HCl 0.05%, emedastine 0.05% and fluorometholone acetate 0.1% ophthalmic solutions for seasonal allergic conjunctivitis: a placebo-controlled environmental trial","volume":"52","author":"Borazan","year":"2022","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jtos.2025.05.003_bib46","unstructured":"de Blay F, Gherasim A, Domis N, Choual I, Bourcier T. Efficacy of N-acetyl aspartyl glutamic acid versus fluorometholone for treating allergic conjunctivitis in an environmental exposure chamber."},{"issue":"1","key":"10.1016\/j.jtos.2025.05.003_bib47","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ophtha.2013.08.007","article-title":"Effectiveness of nonpharmacologic treatments for acute seasonal allergic conjunctivitis","volume":"121","author":"Bilkhu","year":"2014","journal-title":"Ophthalmology"}],"container-title":["The Ocular Surface"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542012425000643?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542012425000643?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T10:53:47Z","timestamp":1752576827000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542012425000643"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":47,"alternative-id":["S1542012425000643"],"URL":"https:\/\/doi.org\/10.1016\/j.jtos.2025.05.003","relation":{},"ISSN":["1542-0124"],"issn-type":[{"value":"1542-0124","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ranking the efficacy of topical treatments for ocular allergy: A network meta-analysis of current evidence","name":"articletitle","label":"Article Title"},{"value":"The Ocular Surface","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtos.2025.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}